Inside the EMA: A Bird's-Eye View of Europe's Medicines Regulator

About this session

Europe's medicines regulator is operating in an increasingly complex environment. Implementation of the EU Health Technology Assessment Regulation, rapid advances in artificial intelligence, geopolitical uncertainty, evolving expectations for scientific transparency, and growing pressure on public institutions are reshaping the landscape in which regulatory decisions are made.

Speakers

• 

  Laura Pizzi

  ISPOR

  Moderator

• 

  Michael Berntgen

  Head of Evidence Generation Department · European Medicines Agency

  Panelist

• 

  Francesco Pignatti

  European Medicines Agency

  Panelist

• DK

  Dominik Karres

  European Medicines Agency

  Panelist